In this episode of the Pharma Matters Podcast, host Ben Locwin speaks with Luca Allievi, R&D Chemist and Project Manager at Valsynthese SA, about how the company has built a reputation as a CDMO capable of handling some of the most challenging chemistries in pharma and fine chemicals.

In this episode of the Pharma Matters Podcast, host Ben Locwin speaks with Luca Allievi, R&D Chemist and Project Manager at Valsynthese SA, about how the company has built a reputation as a CDMO capable of handling some of the most challenging chemistries in pharma and fine chemicals.

In this episode of the Pharma Matters Podcast, host Ben Locwin speaks with Luca Allievi, R&amp;D Chemist and Project Manager at Valsynthese SA, about how the company has built a reputation as a CDMO capable of handling some of the most challenging chemistries in pharma and fine chemicals.

High-Risk Chemistry, Smarter Development: Inside Valsynthese’s CDMO Expertise

Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.&nbsp;

Business

News

Business News

Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels. 

Share High-Risk Chemistry, Smarter Development: Inside Valsynthese’s CDMO Expertise

Sign up to save your podcasts

High-Risk Chemistry, Smarter Development: Inside Valsynthese’s CDMO Expertise

High-Risk Chemistry, Smarter Development: Inside Valsynthese’s CDMO Expertise